Liraglutide
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0143-9144 -
Package NDC
0143-9144-02 -
Package NDC
0143-9144-03 -
Application number
ANDA215503 -
SPL ID
4e2acb7a-d32d-49d3-b59b-39332b5809f3 -
SPL set ID
2100ec49-57b2-4330-ab5f-057ce9b7e4d0 -
UNII
839I73S42A -
RxCUI
897122
What the source publishes
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Active ingredients
- liraglutide
- Form
- INJECTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Liraglutide",
"splId": "4e2acb7a-d32d-49d3-b59b-39332b5809f3",
"labels": [
{
"setId": "2100ec49-57b2-4330-ab5f-057ce9b7e4d0",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2100ec49-57b2-4330-ab5f-057ce9b7e4d0",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2100ec49-57b2-4330-ab5f-057ce9b7e4d0"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "Hikma Pharmaceuticals USA Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "2 SYRINGE, PLASTIC in 1 CARTON (0143-9144-02) / 3 mL in 1 SYRINGE, PLASTIC (0143-9144-01)",
"package_ndc": "0143-9144-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20241224"
},
{
"sample": false,
"description": "3 SYRINGE, PLASTIC in 1 CARTON (0143-9144-03) / 3 mL in 1 SYRINGE, PLASTIC (0143-9144-01)",
"package_ndc": "0143-9144-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20241224"
}
],
"productId": "0143-9144_4e2acb7a-d32d-49d3-b59b-39332b5809f3",
"useDomain": "unknown",
"dosageForm": "INJECTION",
"productNdc": "0143-9144",
"deaSchedule": null,
"genericName": "liraglutide",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LIRAGLUTIDE",
"strength": "6 mg/mL"
}
],
"applicationNumber": "ANDA215503",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20241224",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000178480",
"M0160181",
"N0000020058"
],
"unii": [
"839I73S42A"
],
"rxcui": [
"897122"
],
"spl_set_id": [
"2100ec49-57b2-4330-ab5f-057ce9b7e4d0"
],
"pharm_class_cs": [
"Glucagon-Like Peptide 1 [CS]"
],
"pharm_class_epc": [
"GLP-1 Receptor Agonist [EPC]"
],
"pharm_class_moa": [
"Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
],
"manufacturer_name": [
"Hikma Pharmaceuticals USA Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0143-9144_4e2acb7a-d32d-49d3-b59b-39332b5809f3"